Christoph Bode

Severe energy deprivation of human hibernating myocardium as possible common pathomechanism of contractile dysfunction, structural degeneration and cell death.

Hirudin in acute coronary syndromes.

The GP IIb/IIIa inhibitor abciximab (c7E3) inhibits the binding of various ligands to the leukocyte integrin Mac-1 (CD11b/CD18, alphaMbeta2).

Increased glycolysis as protective adaptation of energy depleted, degenerating human hibernating myocardium.

Independence of growth factor induced plasminogen activator inhibitor type-1 (PAI-1) expression from the 4G/5G polymorphism of the PAI-1 gene.

Adhesion of monocytes to medical steel as used for vascular stents is mediated by the integrin receptor Mac-1 (CD11b/CD18; alphaM beta2) and can be inhibited by semiconductor coating.

Construction and in vitro testing of a novel fab-hirudin-based fusion protein that targets fibrin and inhibits thrombin in a factor xa-dependent manner.

BMPER, a novel endothelial cell precursor-derived protein, antagonizes bone morphogenetic protein signaling and endothelial cell differentiation.

Advanced heart failure requiring three devices for survival.

Reversibility versus persistence of GPIIb/IIIa blocker-induced conformational change of GPIIb/IIIa (alphaIIbbeta3, CD41/CD61).

Reoxygenation of hypoxic coronary smooth muscle cells amplifies growth-retarding effects of ionizing irradiation.

Use of GPIIb/IIIa inhibitors in cardiovascular medicine.

Fibrin-targeted direct factor Xa inhibition: construction and characterization of a recombinant factor Xa inhibitor composed of an anti-fibrin single-chain antibody and tick anticoagulant peptide.

Single-chain antibodies for the conformation-specific blockade of activated platelet integrin alphaIIbbeta3 designed by subtractive selection from naive human phage libraries.

Computed tomography coronary angiography with 370-millisecond gantry rotation time: evaluation of the best image reconstruction interval.

Distinct roles of ligand affinity and cytoskeletal anchorage in alphaIIbbeta3 (GP IIb/IIIa)-mediated cell aggregation and adhesion.

Leukocyte subpopulations and arteriogenesis: specific role of monocytes, lymphocytes and granulocytes.

Images in cardiovascular medicine. Traumatic aortic valve rupture.

Aspirin, but not clopidogrel, reduces collateral conductance in a rabbit model of femoral artery occlusion.

Conformation-specific blockade of the integrin GPIIb/IIIa: a novel antiplatelet strategy that selectively targets activated platelets.

CD40 ligand mediates inflammation independently of CD40 by interaction with Mac-1.

Randomized, double-blind, dose-ranging study of otamixaban, a novel, parenteral, short-acting direct factor Xa inhibitor, in percutaneous coronary intervention: the SEPIA-PCI trial.

STEMI and NSTEMI: the dangerous brothers.

Atrial fibrillation reduces the atrial impedance amplitude during cardiac cycle: a novel detection algorithm to improve recognition of atrial fibrillation in pacemaker patients.

BMPER is a conserved regulator of hematopoietic and vascular development in zebrafish.

Incidence of ventricular tachyarrhythmias during permanent pacemaker therapy in low-risk patients results from the German multicentre EVENTS study.

Anaphylactic shock-associated cardiomyopathy.

Direct thrombin inhibition with bivalirudin as an antithrombotic strategy in general and interventional cardiology.

ERK signaling is a central regulator for BMP-4 dependent capillary sprouting.

Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial.

Rupture of an aneurysm of the noncoronary sinus of Valsalva into the right atrium.

[Innovations in thrombolytic therapy in heart and coronary diseases].

Sirolimus-eluting versus bare-metal stents for the reduction of coronary restenosis: 18-month angiographic results from the GERSHWIN Study.

Intravenous low-molecular-weight heparins compared with unfractionated heparin in percutaneous coronary intervention: quantitative review of randomized trials.

Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.

A contrast agent recognizing activated platelets reveals murine cerebral malaria pathology undetectable by conventional MRI.

Oxygenated perfluorochemicals improve cell survival during reoxygenation by pacifying mitochondrial activity.

Selenium supplementation induces metalloproteinase-dependent L-selectin shedding from monocytes.

Mortality in patients with atrial fibrillation has significantly decreased during the last three decades: 35 years of follow-up in 1627 pacemaker patients.

Increased levels of circulating microparticles in patients with severe aortic valve stenosis.

Predictors of uncontrolled hyperlipidaemia in high-risk ambulatory patients in primary care.

Visualization of activated platelets by targeted magnetic resonance imaging utilizing conformation-specific antibodies against glycoprotein IIb/IIIa.

[Optimal platelet inhibition after coronary stent implantation. Current status].

Simplified contrast ultrasound accurately reveals muscle perfusion deficits and reflects collateralization in PAD.

Functionalized magnetic resonance contrast agent selectively binds to glycoprotein IIb/IIIa on activated human platelets under flow conditions and is detectable at clinically relevant field strengths.

Sustained effects in hypercholesterolaemic patients on combined simvastatin/ezetimibe treatment: observational cohort study in clinical practice.

BMPER is an endothelial cell regulator and controls bone morphogenetic protein-4-dependent angiogenesis.

[Vascular biology and blood coagulation].

Evaluation of urine proteome pattern analysis for its potential to reflect coronary artery atherosclerosis in symptomatic patients.

The use of intravenous enoxaparin in elective percutaneous coronary intervention in patients with renal impairment: results from the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial.

Thrombolysis during resuscitation for out-of-hospital cardiac arrest.

In vivo effect of a dominant negative Kv4.2 loss-of-function mutation eliminating I(to,f) on atrial refractoriness and atrial fibrillation in mice.

Cardiac involvement after respiratory tract viral infection--detection by cardiac magnetic resonance.

Suicide attempt by intravenous injection of gasoline: a case report.

Persistent left superior vena cava: an unusual but conquerable obstacle in device implantation.

Cardiovascular flashlight. Persistent truncus arteriosus: a rare finding in adults.

Differences of platelet adhesion and thrombus activation on amorphous silicon carbide, magnesium alloy, stainless steel, and cobalt chromium stent surfaces.

Evaluation of platelet activation in patients supported by the Jarvik 2000* high-rotational speed impeller ventricular assist device.

Desmoteplase in acute massive pulmonary thromboembolism.

Early versus delayed, provisional eptifibatide in acute coronary syndromes.

Visualization of multidirectional regional left ventricular dynamics by high-temporal-resolution tissue phase mapping.

New antithrombotic agents in acute coronary syndromes.

HoxB5 induces endothelial sprouting in vitro and modifies intussusceptive angiogenesis in vivo involving angiopoietin-2.

EUROSCORE: still gold standard or less?

Endothelial glycocalyx dimensions are reduced in growing collateral arteries and modulate leucocyte adhesion in arteriogenesis.

Inhibition by fibrates of plasminogen activator inhibitor type-1 expression in human adipocytes and preadipocytes.

Impact of stent length on restenosis in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: analysis based on data from the Trial to Assess the Use of the Cypher Stent in Acute Myocardial Infarction Treated with Balloon Angioplasty (TYPHOON).

The need for new oral anticoagulants in clinical practice: an introduction.

Novel antiplatelet therapies following percutaneous coronary interventions.

Patent foramen ovale and cryptogenic stroke: a matter of age?

Non-invasive imaging in the diagnosis of acute viral myocarditis.

Krüppel-like factor 15 regulates BMPER in endothelial cells.

Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention 1-year results from the STEEPLE (SafeTy and efficacy of enoxaparin in percutaneous coronary intervention patients, an international randomized evaluation) trial.

Clopidogrel affects leukocyte dependent platelet aggregation by P2Y12 expressing leukocytes.

Rationale and design of the Patient Related OuTcomes with Endeavor versus Cypher stenting Trial (PROTECT): randomized controlled trial comparing the incidence of stent thrombosis and clinical events after sirolimus or zotarolimus drug-eluting stent implantation.

Magnetic resonance tissue phase mapping of myocardial motion: new insight in age and gender.

Platelets and vascular disease.

Prosthetic valve endocarditis due to Actinomyces neuii successfully treated with antibiotic therapy.

BMPER is upregulated by statins and modulates endothelial inflammation by intercellular adhesion molecule-1.

Transient hyperoxic reoxygenation reduces cytochrome C oxidase activity by increasing superoxide dismutase and nitric oxide.

Hematomas of at least 5 cm and outcomes in patients undergoing elective percutaneous coronary intervention: insights from the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial.

CD40L induces inflammation and adipogenesis in adipose cells--a potential link between metabolic and cardiovascular disease.

Mannose-binding lectin: an ancient molecule with new implications in myocardial infarction.

[Constrictive pericarditis: etiology, diagnostic work-up, and therapy].

Genetic transfer of fusion proteins effectively inhibits VCAM-1-mediated cell adhesion and transmigration via inhibition of cytoskeletal anchorage.

Tumor necrosis factor receptor-associated factor 1 (TRAF1) deficiency attenuates atherosclerosis in mice by impairing monocyte recruitment to the vessel wall.

Incidental finding of a pulmonary embolus by intracardiac echocardiography during an atrial fibrillation ablation procedure.

Antiplatelet therapy for atherothrombotic disease: how can we improve the outcomes?

Enhanced microparticles in ventricular assist device patients predict platelet, leukocyte and endothelial cell activation.

Diagnosis of early myocarditis after respiratory or gastrointestinal tract viral infection: insights from cardiovascular magnetic resonance.

Severe endothelial injury and subsequent repair in patients after successful cardiopulmonary resuscitation.

Patients with acute coronary syndromes and elevated levels of natriuretic peptides: the results of the AVANT GARDE-TIMI 43 Trial.

Early dynamic risk stratification with baseline troponin levels and 90-minute ST-segment resolution to predict 30-day cardiovascular mortality in ST-segment elevation myocardial infarction: analysis from CLopidogrel as Adjunctive ReperfusIon TherapY (CLARITY)-Thrombolysis in Myocardial Infarction (TIMI) 28.

Tumor necrosis factor receptor associated factor 6 is not required for atherogenesis in mice and does not associate with atherosclerosis in humans.

Acute pulmonary embolism and a patent foramen ovale: analysis of atrial right-to-left shunting by biphasic transcardiopulmonary thermodilution curves.

TRAF5 deficiency accelerates atherogenesis in mice by increasing inflammatory cell recruitment and foam cell formation.

Randomized comparison of eptifibatide versus abciximab in primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: results of the EVA-AMI Trial.

Increased platelet, leukocyte and endothelial microparticles predict enhanced coagulation and vascular inflammation in pulmonary hypertension.

An ultrasound contrast agent targeted to P-selectin detects activated platelets at supra-arterial shear flow conditions.

Clopidogrel in acute coronary syndrome: implications of recent study findings.

Success of arterial revascularization determined by contrast ultrasound muscle perfusion imaging.

Nicorandil normalizes prolonged repolarisation in the first transgenic rabbit model with Long-QT syndrome 1 both in vitro and in vivo.

Leptin augments cerebral hemodynamic reserve after three-vessel occlusion: distinct effects on cerebrovascular tone and proliferation in a nonlethal model of hypoperfused rat brain.

Pharmacological activation of Kv11.1 in transgenic long QT-1 rabbits.

Inflammasome activation in reperfusion injury: friendly fire on myocardial infarction?

Evidence for non-ischemic scarring in patients with ventricular ectopy.

A randomized, partially blinded, multicenter, active-controlled, dose-ranging study assessing the safety, efficacy, and pharmacodynamics of the REG1 anticoagulation system in patients with acute coronary syndromes: design and rationale of the RADAR Phase IIb trial.

MicroRNA-100 regulates neovascularization by suppression of mammalian target of rapamycin in endothelial and vascular smooth muscle cells.

Images in cardiovascular medicine. Recurrence of a familial giant multilocular cardiac myxoma in a patient with Carney's complex.

Activated platelets in carotid artery thrombosis in mice can be selectively targeted with a radiolabeled single-chain antibody.

Discontinuation of long term clopidogrel therapy induces platelet rebound hyperaggregability between 2 and 6 weeks post cessation.

Cannabinoid receptor 2 signaling does not modulate atherogenesis in mice.

Redemption by RE-DEEM?

Rationale and design of the Anti-Xa therapy to lower cardiovascular events in addition to standard therapy in subjects with acute coronary syndrome-thrombolysis in myocardial infarction 51 (ATLAS-ACS 2 TIMI 51) trial: a randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rivaroxaban in subjects with acute coronary syndrome.

Molecular magnetic resonance imaging allows the detection of activated platelets in a new mouse model of coronary artery thrombosis.

Shock lead impedance alert: replace or reconsider?

The oral spleen tyrosine kinase inhibitor fostamatinib attenuates inflammation and atherogenesis in low-density lipoprotein receptor-deficient mice.

Pegnivacogin results in near complete FIX inhibition in acute coronary syndrome patients: RADAR pharmacokinetic and pharmacodynamic substudy.

Early Heparin Administration Reduces Risk for Left Atrial Thrombus Formation during Atrial Fibrillation Ablation Procedures.

Measuring oxidative burden and predicting pharmacological response in coronary artery disease patients with a novel direct activator of haem-free/oxidised sGC.

New parenteral anticoagulants: focus on factor Xa and thrombin inhibitors.

Successful in vitro expansion and differentiation of cord blood derived CD34+ cells into early endothelial progenitor cells reveals highly differential gene expression.

BMP activity controlled by BMPER regulates the proinflammatory phenotype of endothelium.

[Atrial fibrillation: what the GP needs to know].

Study design and rationale for the Stabilization of pLaques usIng Darapladib-Thrombolysis in Myocardial Infarction (SOLID-TIMI 52) trial in patients after an acute coronary syndrome.

Binding of CD40L to Mac-1's I-domain involves the EQLKKSKTL motif and mediates leukocyte recruitment and atherosclerosis--but does not affect immunity and thrombosis in mice.

Circulating annexin V positive microparticles in patients after successful cardiopulmonary resuscitation.

Rivaroxaban in patients with a recent acute coronary syndrome.

Thrombin-receptor antagonist vorapaxar in acute coronary syndromes.

Anomalous hypoplastic left anterior descending artery.

Perturbation of the endothelial glycocalyx in post cardiac arrest syndrome.

Urine Proteome Analysis Reflects Atherosclerotic Disease in an ApoE-/- Mouse Model and Allows the Discovery of New Candidate Biomarkers in Mouse and Human Atherosclerosis.

Serotonin antagonism improves platelet inhibition in clopidogrel low-responders after coronary stent placement: an in vitro pilot study.

CD40L deficiency attenuates diet-induced adipose tissue inflammation by impairing immune cell accumulation and production of pathogenic IgG-antibodies.

MicroRNA regulation of angiogenesis and arteriogenesis.

An approach towards molecular imaging of activated platelets allows imaging of symptomatic human carotid plaques in a new model of a tissue flow chamber.

Evidence of myocardial edema in patients with nonischemic dilated cardiomyopathy.

Diagnosis of viral myocarditis by cardiac magnetic resonance and viral genome detection in peripheral blood.

Intracardiac Echocardiography during Catheter-Based Ablation of Atrial Fibrillation.

Development and clinical applications of novel oral anticoagulants. Part I. Clinically approved drugs.

Development and clinical applications of novel oral anticoagulants. Part II. Drugs under clinical investigation.

Impact of chronic kidney disease on long-term clinical outcomes after percutaneous coronary intervention with drug-eluting or bare-metal stents.

A Phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with acute coronary syndromes: results of the RADAR trial.

Rivaroxaban for stroke prevention in atrial fibrillation and secondary prevention in patients with a recent acute coronary syndrome.

MicroRNAs in ischemia-reperfusion injury.

Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial.

Segmental myocardial velocities in dilated cardiomyopathy with and without left bundle branch block.

Diabetes mellitus and myocardial mitochondrial dysfunction: bench to bedside.

Age, gender, blood pressure, and ventricular geometry influence normal 3D blood flow characteristics in the left heart.

Rho-associated coiled-coil-containing kinase 2 deficiency in bone marrow-derived cells leads to increased cholesterol efflux and decreased atherosclerosis.

In vivo detection of activated platelets allows characterizing rupture of atherosclerotic plaques with molecular magnetic resonance imaging in mice.

Transfemoral aortic valve implantation: bleeding events, related costs and outcomes.

TAVI 2012: state of the art.

Design and rationale of the treatment of acute coronary syndromes with otamixaban trial: a double-blind triple-dummy 2-stage randomized trial comparing otamixaban to unfractionated heparin and eptifibatide in non-ST-segment elevation acute coronary syndromes with a planned early invasive strategy.

Editorial comment: Reduction of oxidative stress: a new indication for acetylsalicylic acid in coronary artery bypass surgery.

Platelet serotonin promotes the recruitment of neutrophils to sites of acute inflammation in mice.

Mac-1 directly binds to the endothelial protein C-receptor: a link between the protein C anticoagulant pathway and inflammation?

Inhibition of the renin-angiotensin system reduces the rise in serum aldosterone in acute coronary syndrome patients with preserved left ventricular function: observations from the AVANT GARDE-TIMI 43 trial.

Rationale and design of the EMBRACE STEMI Study: A phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction.

Incidence, treatment, and outcomes of atrial fibrillation complicating non-ST-segment elevation acute coronary syndromes.

Antagonism and synergy between extracellular BMP modulators Tsg and BMPER to balance blood vessel formation.

Inhibition of BMP activity protects epithelial barrier function in lung injury.

Differential effects of the β-adrenoceptor blockers carvedilol and metoprolol on SQT1- and SQT2-mutant channels.

Vector selection of a quadripolar left ventricular pacing lead affects acute hemodynamic response to cardiac resynchronization therapy: a randomized cross-over trial.

Spatial correlation of action potential duration and diastolic dysfunction in transgenic and drug-induced LQT2 rabbits.

Successful therapy of ventricular rupture by percutaneous intrapericardial instillation of fibrin glue: a case report.

Anticoagulation with otamixaban and ischemic events in non-ST-segment elevation acute coronary syndromes: the TAO randomized clinical trial.

FoxP1 stimulates angiogenesis by repressing the inhibitory guidance protein semaphorin 5B in endothelial cells.

Cold ischaemic time and time after transplantation alter segmental myocardial velocities after heart transplantation.

Coronary stent restenosis and occlusion: messages from the dead for the living.

A novel hollow and perforated flexible wire allows the safe and effective local application of thrombolytic therapy in a mouse model of deep vein thrombosis.

Third generation P2Y12 antagonists inhibit platelet aggregation more effectively than clopidogrel in a myocardial infarction registry.

Safety of very early sheath removal in patients treated with REG1 for acute coronary syndromes: insights from the RADAR trial.

The transcription factor HoxB5 stimulates vascular remodelling in a cytokine-dependent manner.

Triple antithrombotic therapy in cardiac patients: more questions than answers.

Severe mitral regurgitation requiring ECMO therapy treated by interventional valve reconstruction using the MitraClip.

Anticoagulants for secondary prevention after acute myocardial infarction: lessons from the past decade.

Acute fluoxetine treatment induces slow rolling of leukocytes on endothelium in mice.

Clinical utility of rivaroxaban in stroke prevention associated with nonvalvular atrial fibrillation - patient considerations.

Practical guidance for using rivaroxaban in patients with atrial fibrillation: balancing benefit and risk.

Coinhibitory suppression of T cell activation by CD40 protects against obesity and adipose tissue inflammation in mice.

Remote ICD-monitoring in detection and follow-up of triggers of idiopathic ventricular fibrillation: implications for the clinical management of IVF patients.

Acute results and long-term follow-up of patients with accompanying myocarditis after viral respiratory or gastrointestinal tract infection.

Direct oral anticoagulants in acute coronary syndrome.

Haemodynamic vector personalization of a quadripolar left ventricular lead used for cardiac resynchronization therapy: use of surface electrocardiogram and interventricular time delays.

Dual-contrast molecular imaging allows noninvasive characterization of myocardial ischemia/reperfusion injury after coronary vessel occlusion in mice by magnetic resonance imaging.

Chronic variable stress activates hematopoietic stem cells.

Practice patterns and clinical outcomes among non-ST-segment elevation acute coronary syndrome (NSTE-ACS) patients presenting to primary and tertiary hospitals: insights from the EARLY glycoprotein IIb/IIIa inhibition in NSTE-ACS (EARLY-ACS) trial.

A high ratio of ADP-TRAP induced platelet aggregation is associated more strongly with increased mortality after coronary stent implantation than high conventional ADP induced aggregation alone.

P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice.

Endeavour zotarolimus-eluting stent reduces stent thrombosis and improves clinical outcomes compared with cypher sirolimus-eluting stent: 4-year results of the PROTECT randomized trial.

Role of striatal NMDA receptor subunits in a model of paroxysmal dystonia.

Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial.

Immune functions of platelets.

Pronounced effects of HERG-blockers E-4031 and erythromycin on APD, spatial APD dispersion and triangulation in transgenic long-QT type 1 rabbits.

Mineralocorticoids in the heart and vasculature: new insights for old hormones.

Role of microparticles in endothelial dysfunction and arterial hypertension.

Antiplatelet and anticoagulation agents in acute coronary syndromes: what is the current status and what does the future hold?

How can we optimize the processes of care for acute coronary syndromes to improve outcomes?

Analysis of the additional costs of clinical complications in patients undergoing transcatheter aortic valve replacement in the German Health Care System.

"Heart Team" decision making in elderly patients with symptomatic aortic valve stenosis who underwent AVR or TAVI - a look behind the curtain. Results of the prospective TAVI Calculation of Costs Trial (TCCT).

Fibroblast growth factor signaling pathway in endothelial cells is activated by BMPER to promote angiogenesis.

In vivo contact force measurements and correlation with left atrial anatomy during catheter ablation of atrial fibrillation.

Author's reply: To PMID 24895019.

Two-year survival of patients screened for transcatheter aortic valve replacement with potentially malignant incidental findings in initial body computed tomography.

Myocardial mitochondrial and contractile function are preserved in mice lacking adiponectin.

Magnetic resonance imaging of bioresorbable vascular scaffolds: potential approach for noninvasive evaluation of coronary patency.

Unprotected left main percutaneous coronary intervention in acute coronary syndromes with extracorporeal life support backup.

An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin K antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention (PIONEER AF-PCI).

MicroRNA-155 Exerts Cell-Specific Antiangiogenic but Proarteriogenic Effects During Adaptive Neovascularization.

Selenium prevents microparticle-induced endothelial inflammation in patients after cardiopulmonary resuscitation.

MicroRNA-155 aggravates ischemia-reperfusion injury by modulation of inflammatory cell recruitment and the respiratory oxidative burst.

SIRT3 deficiency impairs mitochondrial and contractile function in the heart.

Myocardial mitochondrial dysfunction in mice lacking adiponectin receptor 1.

Pulmonary vein stenosis after pulmonary vein isolation using duty-cycled unipolar/bipolar radiofrequency ablation guided by intracardiac echocardiography.

The Diagnosis, Risk Stratification, and Treatment of Brugada Syndrome.

Preprocedural planning and implantation of a transcatheter aortic valve without the use of contrast agent.

Adrenergic Repression of the Epigenetic Reader MeCP2 Facilitates Cardiac Adaptation in Chronic Heart Failure.

Mitochondrial Mechanisms in Septic Cardiomyopathy.

[Prophylaxis of thromboembolism in atrial fibrillation: new oral anticoagulants and left atrial appendage closure].

Clinical potential of vorapaxar in cardiovascular risk reduction in patients with atherosclerosis.

In-hospital resource utilization in surgical and transcatheter aortic valve replacement.

Aortic root volume is associated with contained rupture of the aortic annulus in balloon-expandable transcatheter aortic valve replacement.

Preserved recovery of cardiac function following ischemia-reperfusion in mice lacking SIRT3.

Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial.

Deoxycorticosterone Acetate/Salt-Induced Cardiac But Not Renal Injury Is Mediated By Endothelial Mineralocorticoid Receptors Independently From Blood Pressure.

Platelet-neutrophil complex formation-a detailed in vitro analysis of murine and human blood samples.

Patients with exercise-associated ventricular ectopy present evidence of myocarditis.

Response to Letter Regarding Article, "MicroRNA-155 Exerts Cell-Specific Antiangiogenic but Proarteriogenic Effects During Adaptive Neovascularization".

Effect of Availability of Transcatheter Aortic-Valve Replacement on Clinical Practice.

Atheroprotection through SYK inhibition fails in established disease when local macrophage proliferation dominates lesion progression.

A randomized trial to compare the safety of rivaroxaban vs aspirin in addition to either clopidogrel or ticagrelor in acute coronary syndrome: The design of the GEMINI-ACS-1 phase II study.

Hsp70 preventing thrombosis: benefit without burden?

Recurrent pulseless electrical activity in a patient with coronary vasospasm and supravalvular aortic stenosis: a case report.

Acute exposure to air pollution particulate matter aggravates experimental myocardial infarction in mice by potentiating cytokine secretion from lung macrophages.

Optimal number of image slices for reliable measurement of left ventricular volumes and ejection fraction by three-dimensional transesophageal echocardiography.

Extracellular ATP Induces Vascular Inflammation and Atherosclerosis via Purinergic Receptor Y2 in Mice.

MnTBAP increases BMPR-II expression in endothelial cells and attenuates vascular inflammation.

Pre-existing anti-PEG antibodies are associated with severe immediate allergic reactions to pegnivacogin, a PEGylated aptamer.

A critical reappraisal of aspirin for secondary prevention in patients with ischemic heart disease.

Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy.

Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI.

Bone Morphogenetic Protein-Modulator BMPER Regulates Endothelial Barrier Function.

Diabetic Cardiomyopathy: Does the Type of Diabetes Matter?

The neuronal transcription factor NPAS4 is a strong inducer of sprouting angiogenesis and tip cell formation.

Corrigendum to "A critical reappraisal of aspirin for secondary prevention in patients with ischemic heart disease" [Am Heart J 181 (2016) 92-100].

Towards a cardiac allocation score: a retrospective calculation for 73 patients from a German transplant center.

Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial.

P2X Deficiency Blocks Lesional Inflammasome Activity and Ameliorates Atherosclerosis in Mice.

Direct factor IXa inhibition with the RNA-aptamer pegnivacogin reduces platelet reactivity in vitro and residual platelet aggregation in patients with acute coronary syndromes.

Inhibition of the cardiac myocyte mineralocorticoid receptor ameliorates doxorubicin-induced cardiotoxicity.

Time matters in patients undergoing extracorporeal cardiopulmonary resuscitation.

Phase-contrast magnet resonance imaging reveals regional, transmural, and base-to-apex dispersion of mechanical dysfunction in patients with long QT syndrome.

Lethal pulmonary hemorrhage syndrome due to Leptospira infection transmitted by pet rat.

The mitochondria-targeting peptide elamipretide diminishes circulating HtrA2 in ST-segment elevation myocardial infarction.

Influence of low-flow time on survival after extracorporeal cardiopulmonary resuscitation (eCPR).

Interregional electro-mechanical heterogeneity in the rabbit myocardium.

Endothelial BMP4 Regulates Leukocyte Diapedesis and Promotes Inflammation.

The Effects of Serotonin in Immune Cells.

A molecular intravascular ultrasound contrast agent allows detection of activated platelets on the surface of symptomatic human plaques.

Chip-based digital PCR as a novel detection method for quantifying microRNAs in acute myocardial infarction patients.

MicroRNA-100 Suppresses Chronic Vascular Inflammation by Stimulation of Endothelial Autophagy.

Gene expression analysis to identify mechanisms underlying heart failure susceptibility in mice and humans.

Cardiac Endothelial Cell Transcriptome.

Means for Transport in Patients After Remote Extracorporeal Membrane Oxygenation Implantation.

Inflammatory Pathways Regulated by Tumor Necrosis Receptor-Associated Factor 1 Protect From Metabolic Consequences in Diet-Induced Obesity.

Coronary magnetic resonance imaging after routine implantation of bioresorbable vascular scaffolds allows non-invasive evaluation of vascular patency.

A ligand-specific blockade of the integrin Mac-1 selectively targets pathologic inflammation while maintaining protective host-defense.

Isoflurane or propofol sedation in patients with targeted temperature management after cardiopulmonary resuscitation: A single center study.

Effect of Procedure and Coronary Lesion Characteristics on Clinical Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights From the PIONEER AF-PCI Trial.

Risk factors and outcome of postoperative delirium after transcatheter aortic valve replacement.

The effect of oxygen in Sirt3-mediated myocardial protection: a proof-of-concept study in cultured cardiomyoblasts.

Fluid therapy remains an important cornerstone in the prevention of progressive chugging in extracorporeal membrane oxygenation.

Total bleeding with rivaroxaban versus warfarin in patients with atrial fibrillation receiving antiplatelet therapy after percutaneous coronary intervention.

A novel LMNA nonsense mutation causes two distinct phenotypes of cardiomyopathy with high risk of sudden cardiac death in a large five-generation family.